NCT06628986 MBSR and NLP, Postpartum Breastfeeding and Depression
| NCT ID | NCT06628986 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aysegul Kilicli |
| Condition | Breastfeeding, Exclusive |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-10-08 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-10-08 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The postnatal period is a risky period in which mothers experience regressive and progressive changes and rapid biopsychosocial changes. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes that occur in this period.
Eligibility Criteria
Inclusion Criteria: * 19-35 years old * caesarean section * primiparous * breastfeeding women Exclusion Criteria: * women who refused to participate in the research.
Contact & Investigator
AYŞEGÜL KILIÇLI, Dr.
STUDY DIRECTOR
Muş Alparslan University
Frequently Asked Questions
Who can join the NCT06628986 clinical trial?
This trial is open to female participants only, aged 19 Years or older, up to 35 Years, studying Breastfeeding, Exclusive. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06628986 currently recruiting?
Yes, NCT06628986 is actively recruiting participants. Contact the research team at aysegul_ay_9@hotmail.com for enrollment information.
Where is the NCT06628986 trial being conducted?
This trial is being conducted at Sanliurfa, Turkey (Türkiye).
Who is sponsoring the NCT06628986 clinical trial?
NCT06628986 is sponsored by Aysegul Kilicli. The principal investigator is AYŞEGÜL KILIÇLI, Dr. at Muş Alparslan University. The trial plans to enroll 90 participants.